GFBiochemicals Acquires Segetis, Enters the US Market
by Jim Lane (Biofuels Digest) In Washington, GFBiochemicals announced at ABLC 2016 that it has acquired the assets and intellectual property of Segetis, a US-based, venture-backed levulinic acid derivatives producer Segetis has more than 50 patents and over 200 pending patent